TW558565B - The process for preparing the yeast containing recombinant lactoferrin - Google Patents

The process for preparing the yeast containing recombinant lactoferrin Download PDF

Info

Publication number
TW558565B
TW558565B TW89118646A TW89118646A TW558565B TW 558565 B TW558565 B TW 558565B TW 89118646 A TW89118646 A TW 89118646A TW 89118646 A TW89118646 A TW 89118646A TW 558565 B TW558565 B TW 558565B
Authority
TW
Taiwan
Prior art keywords
lactoferrin
yeast
recombinant
dna
culture
Prior art date
Application number
TW89118646A
Other languages
Chinese (zh)
Inventor
Sue-Hong Wang
Simon Jen-Tan Mao
Original Assignee
Pig Res Inst Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pig Res Inst Taiwan filed Critical Pig Res Inst Taiwan
Priority to TW89118646A priority Critical patent/TW558565B/en
Application granted granted Critical
Publication of TW558565B publication Critical patent/TW558565B/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

This invention relates to production of yeast strains constructed to contain recombinant porcine lactoferrin, which includes construction of expression vectors of porcine recombinant lactoferrin and culturing of yeast containing lactoferrin. This invention process combines yeast fermentation and recombinant lactoferrin expression at the same time and need no purification of recombinant lactoferrin.

Description

558565 '~----- 五、發明說明(1) 一 ·背景: 乳鐵蛋白是一種會與鐵結合的蛋白質,分子量大約 7 8 kDa,可結合兩個鐵,其與鐵的結合是可逆的。因此可 提供鐵給予需鐵的細胞,亦可搶其鐵,因而抑制微生物的 生存(Vorland, L· Η·( 1 9 9 9 ) APMIS 107, 9 7 1 - 9 8 1 ) 乳鐵蛋白在乳中的含量相當高,在哺乳的過程中乳鐵 蛋白可將鐵傳送給新生哺乳動物。哺乳的嬰兒比餵食牛乳 的嬰兒因鐵缺乏而造成貧血的機會較少,小豬若餵食給含 乳鐵蛋白的飼料,可避免内毒素所造成的休克死亡(Lee, W· J·等人(1998) Infect. Immun. 66, 142卜1426·),且 可增加肝細胞蛋白質的合成(Burrin, D. C.等人(1996) Pediatr· Res· 40, 7 2 - 7 6 ),除此之外也可保護新生哺乳 動物腸胃道免受微生物感染並促進腸細胞的生長(Brooke, J· (1995) Immunol. Today 16, 417-419) 0 乳鐵蛋白除了存在於人奶及一切哺乳動物的奶中,也 存在於唾液,淚液,氣管,鼻腔分泌物,胰液以及其他的 身體分泌物中(Masson, P· L·及Heremans, J· F· (1971) Comp. Biochem. Physiol. 39B, 119-129),具有殺菌及麵 抑菌的作用,因此乳鐵蛋白可應用在日常食品或家畜上防 _ 止微生物感染,提高乳中乳鐵蛋白的量或在新生哺乳動物 飼料中添加乳鐵蛋白可提高其非專一性免疫能力及避免貧558565 '~ ----- 5. Description of the invention (1) 1. Background: Lactoferrin is a protein that binds to iron, with a molecular weight of about 78 kDa. It can bind two irons, and its binding with iron is reversible. of. Therefore, iron can be provided to cells that require iron, and iron can also be grabbed, thereby inhibiting the survival of microorganisms (Vorland, L · Η · (1 9 9 9) APMIS 107, 9 7 1-9 8 1) Lactoferrin in milk The content is quite high, and lactoferrin can transfer iron to newborn mammals during breastfeeding. Lactating infants are less likely to cause anemia due to iron deficiency than infants who are fed cow milk. Piglets fed to lactoferrin-containing feeds can avoid shock death caused by endotoxin (Lee, W.J. et al. ( 1998) Infect. Immun. 66, 142, 1426 ·), and can increase the synthesis of hepatocyte proteins (Burrin, DC et al. (1996) Pediatr · Res · 40, 7 2-7 6) Protects the gastrointestinal tract of newborn mammals from microbial infection and promotes the growth of intestinal cells (Brooke, J. (1995) Immunol. Today 16, 417-419) 0 Lactoferrin is found in human milk and all mammal milk, It is also present in saliva, tears, trachea, nasal secretions, pancreatic fluid, and other body secretions (Masson, P.L. and Heremans, J.F. (1971) Comp. Biochem. Physiol. 39B, 119-129) It has bactericidal and bacteriostatic effects, so lactoferrin can be applied to daily food or livestock to prevent microbial infection, increase the amount of lactoferrin in milk or add lactoferrin to the feed of newborn mammals. Non-specific immunity and Avoid poverty

第4頁 558565 五、發明說明(2) 血下痛j的發生(Moreau, M. C·等人(1983) Ann. Microbiol. 134, 429-441) 〇 乳鐵蛋白在人奶的含量最高,但人奶的取得有限,且 有病毒感染等潛在危險因子的存在。而其他的動物如牛, 羊,豬等的含量相對的低很多,因此利用基因工程的方式 量產乳鐵蛋白是解決的方法之一。過去有人利用基因工程 的方式量產重組乳鐵蛋白如專利US 6 0 8 0 5 5 9、US 6 0 6 6 4 6 9及 U S 6 1 0 0 0 5 4,但由於仍需經過回收純化的步驟,因此仍相 當費時,所費也不資。 在我們發明中的特點是我們利用酵母菌表達重組乳鐵 蛋白,但並不純化乳鐵蛋白,而是利用酵母菌作為攜帶 者,直接把帶有乳鐵蛋白的酵母菌作為飼料添加或食品添 加物。 酵母菌本身為飼料添加早已行之有年,酵母菌添加至 飼料中可增加泌乳量,日增重及飼料使用效率(W i 1 1 i a m s, Ρ·Ε·等人(1991) J· Anim.Sci. 6 9,3 0 1 6 - 3 0 2 6 )。過去人 類以抗生素治療時所造成的腸道不適也常以酵母菌作為治 療或預防的藥劑。酵母菌並不是腸胃道的常駐性菌叢也不 會吸附至上皮細胞,但可吸附病原菌,如:白色念珠菌 (Candida albicans),避免病源菌吸附至腸細胞。另外酵 母菌細胞壁的成份也可刺激免疫反應,因此目前酵母菌也Page 4 558565 V. Description of the invention (2) The occurrence of subcutaneous pain j (Moreau, M.C. et al. (1983) Ann. Microbiol. 134, 429-441) o The highest content of lactoferrin in human milk, However, access to human milk is limited and there are potential risk factors such as viral infection. The content of other animals, such as cattle, sheep, and pigs, is relatively low, so using genetic engineering to mass produce lactoferrin is one of the solutions. In the past, some people used genetic engineering to mass-produce recombinant lactoferrin, such as the patents US 6 0 0 5 5 9, US 6 0 6 6 4 6 9 and US 6 1 0 0 0 5 4. The steps are therefore still quite time consuming and costly. The feature in our invention is that we use yeast to express recombinant lactoferrin, but do not purify lactoferrin, but use yeast as a carrier, and directly add lactoferrin-containing yeast as feed or food. Thing. Yeasts have been added to feeds for a long time. Yeasts added to feeds can increase milk production, daily weight gain and feed use efficiency (W i 1 1 iams, P.E. et al. (1991) J. Anim. Sci. 6 9, 3 0 1 6-3 0 2 6). In the past, intestinal discomfort caused by antibiotics in humans has often used yeast as a treatment or prevention agent. Yeast is not a resident flora of the gastrointestinal tract and will not adsorb to epithelial cells, but can adsorb pathogenic bacteria, such as Candida albicans, to prevent pathogenic bacteria from adsorbing to intestinal cells. In addition, the components of the cell wall of the yeast can also stimulate the immune response.

第5頁 55奶65 五、發明說明(3) 常是健康食品的組成份之一。 本發明結合酵母菌與乳鐵蛋白的優點,作為飼料添加 或食品添加物,並可以降低純化乳鐵蛋白所需成本。 二.概述: 本發明相關於一種帶有重組乳鐵蛋白酵母菌的製備, 此轉形的酵母菌體内帶有可表現乳鐵蛋白的表現載體,可 成功的表現乳鐵蛋白的酵母菌,可直接作為飼料添加或作 為健康食品的組成之一。 以基因工程的方式表現重組蛋白的系統有很多,從低 等的細菌到高等的動物細胞及轉殖動物都可以,而其中的 差別在於真核系統具有蛋白質的修飾作用,如醣化作用, 而原核系統沒有。 本發明中的酵母菌系統即屬於最簡單的真核系統,具 有相當的蛋白質修飾作用,因此較能模擬原始真核蛋白的 修飾作用,以酵母菌表達乳鐵蛋白後,此帶有乳鐵蛋白的 酵母菌,可直接作為食品添加或飼料添加而可以降低純化 回收所須花費的成本,也可以結合酵母菌與乳鐵蛋白的功 效使其效力提高。Page 5 55 Milk 65 5. Description of the invention (3) Often it is one of the components of healthy food. The invention combines the advantages of yeast and lactoferrin, and can be used as a feed or food additive, and can reduce the cost required for purifying lactoferrin. 2. Overview: The present invention relates to the preparation of a yeast with recombinant lactoferrin, and the transformed yeast has a lactoferrin-expressing carrier in it, which can successfully express lactoferrin. Can be added directly as feed or as a component of healthy food. There are many systems for expressing recombinant proteins genetically, ranging from lower bacteria to higher animal cells and transgenic animals. The difference is that eukaryotic systems have protein modification functions, such as saccharification, and prokaryotes. The system does not. The yeast system in the present invention belongs to the simplest eukaryotic system, and has considerable protein modification effect, so it can better simulate the modification effect of the original eukaryotic protein. After the lactoferrin is expressed by yeast, the lactoferrin The yeast can be directly added as food or feed, which can reduce the cost of purification and recovery. It can also combine the efficacy of yeast and lactoferrin to improve its effectiveness.

第6頁 558565 五、發明說明(4) 首先建構能在酵母菌細胞表現的乳鐵蛋白表現載體, 乳鐵蛋白表現載體進_入酵母菌後,可以質體的形式存在或 嵌入染色體DNA中,乳鐵蛋白表現載體的組成包括啟動子 (promoter),訊號序列(signal peptide)及豬乳鐵蛋白的 c D N A。重組蛋白表現的時機即決定於啟動子的啟動形式與 時機: (1 ) 誘導式,在一般生長狀況下不表現,只有在加入誘導 物後’才可啟動啟動子使基因表現,如酒精氧化酵素 (alcohol oxidase)啟動子(A0X)須加入甲醇(methanol)啟 動A0X;另外如半乳糖調控的啟動子(GALi*GAL10),在以φ 半乳糖取代葡萄糖的條件下基因才會表現;另外如銅調控 酵母菌金屬硫蛋白(copper responsive yeast metallothioneirOCUPl啟動子在加入銅之後才會表現。 (2 )·持續式:另一類的啟動子則是與細菌生長同步持續性 =表現,如酵母菌以醣類代謝物作為生長所須炭源,因此 >與膽類代谢酵素如甘油醛3_磷酸鹽去氫酵素 iLylerrld?ydr3'Ph〇SPhate dehydrogenase)(GAP) 會持續的表現’因此GAP的啟動子的啟動是持續式的。 本發明所選用的啟動早么会& 如GAP,及半乳糖調控的動啟子動為早^與醋類代謝酵素之啟動子 白表現載體的酵母菌在二動人V:GAL1 ’因此帶有乳鐵蛋 ^ 叙含葡萄糖的生長培養基或以半Page 6 558565 V. Description of the invention (4) First, construct a lactoferrin expression vector that can be expressed in yeast cells. After the lactoferrin expression vector enters the yeast, it can exist in the form of plastids or be embedded in chromosomal DNA. The composition of the lactoferrin expression vector includes a promoter, a signal peptide, and c DNA of porcine lactoferrin. The timing of the expression of the recombinant protein is determined by the promoter's starting form and timing: (1) Induced type, which does not perform under normal growth conditions. Only after the inducer is added can the promoter be activated for gene expression, such as alcohol oxidase (alcohol oxidase) promoter (A0X) must be added to methanol (methanol) to start A0X; In addition, such as galactose-regulated promoter (GALi * GAL10), the gene will be expressed under the condition that φ galactose is used to replace glucose; Regulatory yeast metallothionein (copper responsive yeast metallothioneirOCUPl promoter will be expressed only after adding copper. (2) · continuous: another type of promoter is synchronized with the growth of bacteria = persistence, such as yeast with sugars Metabolites serve as a carbon source for growth, so > and bile metabolizing enzymes such as glyceraldehyde 3-phosphate dehydrogenase iLylerrld? Ydr3'Ph0SPhate dehydrogenase (GAP) will continue to perform 'so the GAP promoter Startup is continuous. The yeast used in the present invention, such as GAP, and galactose-regulated promoters, act as early ^ and vinegar metabolic enzymes, and the promoter of the white expression vector is yeast V: GAL1. Therefore, Lactoferritin ^ Glucose-containing growth medium or

55^5,65 五、發明說明(5) 乳糖取代葡萄糖之培養基生長,即有乳鐵蛋白的表現,不 必外加一些有機溶液減重金屬,因此可將帶有乳鐵蛋白的 酵母菌與培養液直接共同回收利用添加至飼料中,同時也 可簡化帶有乳鐵蛋白酵母菌的製程。 本發明所使用的啟動子例如G A P啟動子或G A L 1調控的 啟動子及終止序列如C Y C I或A Ο X 1終止序列都是酵母菌細胞 本身所擁有的,因此酵母菌對其辨識能力將比其他外源性 的啟動或終止序列來的好。 本發明製備帶有乳鐵蛋白的酵母菌所使用的培養基,+ 為一般含葡萄糖的培養基,在實驗室規模培養時間大約2 天可達到飽和態,可同時加入0-lOOuM氣化鐵(FeCl3 )並不 會影響酵母菌的生長,卻可使帶有乳鐵蛋白的酵母菌同時 帶有鐵,作為飼料添加物時可減少離乳小豬發生貧血的機 會。 目前在台灣,並無有效且經濟的方式來生產乳鐵蛋 白,只有以基因轉殖豬來量產豬的乳鐵蛋白,但仍面臨須 純化的成本效益問題。本發明以酵母菌表現豬的乳鐵蛋 白,可結合酵母菌與乳鐵蛋白的雙重優點,並可降低純化 _ 所需付出的經濟成本。 _ 帶有乳鐵蛋白的酵母菌可直接作為飼料添加物,尤其55 ^ 5,65 5. Description of the invention (5) Growth of lactose-replaced glucose medium, that is, the performance of lactoferrin, there is no need to add some organic solution to reduce heavy metals, so the yeast with lactoferrin and the culture solution can be directly Co-recycling and adding to feed can also simplify the process of yeast with lactoferrin. The promoters used in the present invention, such as the GAP promoter or the GAL 1-regulated promoter and termination sequences such as the CYCI or A 0 X 1 termination sequences, are owned by the yeast cell itself, so the yeast ’s ability to recognize them will be better than other Exogenous start or stop sequences come in well. The medium used for preparing yeast with lactoferrin according to the present invention is a medium containing glucose in general, which can reach a saturated state in a laboratory-scale culture time of about 2 days, and 0-lOOuM gasified iron (FeCl3) can be added simultaneously. It does not affect the growth of yeast, but it can make yeast with lactoferrin to carry iron at the same time, as a feed supplement, it can reduce the chance of anemia in weaned piglets. At present, there is no effective and economical way to produce lactoferrin in Taiwan. Only transgenic pigs are used to mass produce lactoferrin in pigs, but they still face the cost-effectiveness of purification. The present invention expresses pig's lactoferrin by yeast, which can combine the dual advantages of yeast and lactoferrin, and can reduce the economic cost required for purification. _ Yeast with lactoferrin can be used directly as a feed supplement, especially

第8頁 55^565 五、發明說明(6) 是離乳小豬經常發生的貧血下痢造成的死亡,可藉由乳鐵 蛋白酵母的添加而增-加其育成率,另外乳鐵蛋白酵母菌如 同維生素酵母菌一樣也可作為健康食品的添加物。Page 8 55 ^ 565 V. Description of the invention (6) Death caused by anemia and diarrhea that often occurs in weaned piglets can be increased by adding lactoferrin yeast-plus its fertility rate. In addition, lactoferrin yeast is like Vitamin yeast can also be used as an additive to health foods.

第9頁 558565 五、發明說明(7) 圖式之簡單說明: -圖1為豬的乳鐵蛋白之c D N A序列。 圖2為Pichia pastoris中乳鐵蛋白表現載體的構築示意 圖。 圖3顯示麵包酵母菌(Saccharomyces cerevisiae)中乳鐵 蛋白表現載體的構築示意圖。 圖4顯示以西方吸潰(Western blot)分析Pichia pastoris 酵母菌株培養液或細胞内重組乳鐵蛋白的表現結果。 圖5顯示以西方吸潰分析麵包酵母Saccharomyces c e r e v i s i a酵母菌株細胞内重組乳鐵蛋白的表現。 圖6轉形酵母菌Pichia pastoris培養液以heparin 親和性管柱層析純化重組乳鐵蛋白及純化出的重組乳鐵 蛋白的S D S -丙烯醯凝膠電泳結果。 圖7為:顯示重組乳鐵蛋白與鐵結合的吸收光譜。Page 9 558565 V. Description of the invention (7) Brief description of the drawings:-Figure 1 shows the c D N A sequence of pig lactoferrin. Figure 2 is a schematic diagram of the construction of a lactoferrin expression vector in Pichia pastoris. Fig. 3 shows the construction of a lactoferrin expression vector in Saccharomyces cerevisiae. Figure 4 shows the results of Western blot analysis of Pichia pastoris yeast strain culture medium or intracellular recombinant lactoferrin. Figure 5 shows the expression of recombinant lactoferrin in the yeast strain Saccharomyces c e r e v i s i a yeast strain by Western blot analysis. Figure 6 S DS-acrylic acid gel electrophoresis results of purified lactoferrin and purified recombinant lactoferrin purified by Pichia pastoris culture medium using heparin affinity column chromatography. FIG. 7 is an absorption spectrum showing the binding of recombinant lactoferrin to iron.

第10頁 558565 五、發明說明(8) 本發明中之酵母菌帶有豬的乳鐵蛋白,其中豬的重組 乳鐵蛋白經過定性分析包括西方吸漬、二維電泳分析 (2 D )、鐵的結合試驗、及N端氨基酸序列分析都與豬乳乳 鐵蛋白相似。 〇 本發明中之酵母菌帶有豬的乳鐵蛋白已於2000年7月 1 1日依照中華民國專利法被寄存於中華民國台灣新竹食品 工業發展研究所,且被指定寄存編號為CCRC 9 4 0 3 1 0及 CCRC 920022 ° 三.詳細說明: 帶有乳鐵蛋白的酵母菌的製備。所選用的酵母菌包括 Pichia pastoris及麵包酵母Saccharomyces cerevisiae。 (一)·帶有乳鐵蛋白的Pichia pastoris的製備:Page 10 558565 V. Description of the invention (8) The yeast in the present invention contains pig lactoferrin, and the qualitative analysis of pig recombinant lactoferrin includes western blotting, two-dimensional electrophoresis analysis (2D), iron The binding test and N-terminal amino acid sequence analysis were similar to porcine lactoferrin. 〇 The yeast-bearing pig lactoferrin in the present invention was deposited with the Taiwan Hsinchu Food Industry Development Institute in accordance with the Patent Law of the Republic of China on July 11, 2000, and the designated deposit number was CCRC 9 4 0 3 1 0 and CCRC 920022 ° III. Detailed description: Preparation of yeast with lactoferrin. The selected yeasts include Pichia pastoris and Saccharomyces cerevisiae. (1) Preparation of Pichia pastoris with lactoferrin:

第11頁 558565 五、發明說明(9) 首先選用合適的表現^ ^ A ^ 醛3-磷酸鹽去氫酵素βΑΡ啟^’/現的//包括甘油 序列。以聚合酵素連鎖反^子】及酒精氧化,素_終止 • λ ^ ^ . ^'vPolymerase chain react 1〇n)的方式複製出包含豬訊號序列及成熟豬 白c D N A的D N A片段,聚合酵幸诖@ 载蛋 子I連鎖反應複製時所使用 c 板為來自於豬乳腺cDNA庫的乳鐵蛋白cDNA質體含乳鐵蛋白 cDNA的片段,及表現載體同樣經過SfuI&XbaI酵素截切後 進行接合反應,再送入大腸桿菌DH5a進行複製繁殖,以 酵素截切及聚合酵素連鎖反應的方式確認表現載體及乳鐵 蛋白cDNA片段是否接合成功,確定後再將含乳鐵蛋白cDna 的表現載體進行D N A序列分析確認g A P啟動子-乳鐵蛋白 一 D N A - A 0 X ί終止序列之間的序列是否正確,篩選出乳鐵蛋 白表現載體送入DH5 α大量複製後,抽取質體DNA以Avr Π 截切後’線性質體DNA以電脈衝(eiectr〇ph〇rati〇n)的方 式送入Pichia pastoris後,以含Zeocine抗生素的培養基 篩選高抗性的酵母菌株,並培養在5毫升的γ p D培養液經2 天的培養後,以離心的方式分開酵母菌體及培養液,菌體 以玻離珠打破後離心取上清液,以西方吸潰確認乳鐵蛋白 的表現,培養液則濃縮1 0倍後,同樣以西方吸潰確認乳鐵 蛋白的表現。 (一)· f有乳鐵蛋白的麵包酵母菌Sacchoromyces cerevisiae 的製備··Page 11 558565 V. Description of the invention (9) First, select the appropriate expression ^ ^ A ^ aldehyde 3-phosphate dehydrogenase βAP ^ '/ present // including glycerol sequence. Polymerase chain reaction and alcohol oxidation, _ termination • λ ^ ^. ^ 'VPolymerase chain react 10) method to copy the DNA fragment containing the pig signal sequence and mature pig white c DNA, polymerase诖 @ 蛋蛋 子 I chain reaction replication used in the c-plate is a lactoferrin cDNA plastid-containing lactoferrin cDNA fragment from the porcine mammary gland cDNA library, and the expression vector is also cut by SfuI & XbaI enzyme for ligation reaction Then, send it to E. coli DH5a for replication and reproduction, and confirm whether the expression vector and the lactoferrin cDNA fragment are successfully joined by means of enzyme truncation and polymerase chain reaction. After confirmation, perform DNA sequence analysis on the expression vector containing lactoferrin cDna Confirm whether the sequence between the g AP promoter-lactoferrin-DNA-A 0 X ί termination sequence is correct, select the lactoferrin expression vector and send it to DH5 α for a large number of copies, then extract the plastid DNA and cut it with Avr Π 'Linear DNA was sent to Pichia pastoris by electric pulse (eiectrophophration), and a highly resistant yeast strain was selected in a medium containing Zeocine antibiotics. And cultured in 5 ml of γ p D culture solution. After 2 days of culture, the yeast cells and the culture solution were separated by centrifugation. After the cells were broken by glass beads, the supernatant was centrifuged to confirm the milk. The performance of ferritin was 10 times more concentrated in the culture medium, and the performance of lactoferrin was also confirmed by Western suction. (A) Preparation of Sacchoromyces cerevisiae, a baker's yeast with lactoferrin ...

第12頁 558565 五、發明說明(ίο) 表現載體組成包括GAL1啟動子及細胞色素c氧化酵素 (cytochrome-c-oxi(iase)CYCi終止序列。同樣以聚合酵素 連鎖反應的方式複製出含有豬訊號序列及成熟豬乳鐵蛋白 cDNA的DNA片段,將此DNA片段及表現載體以SacI截切再進 行接合反應,轉型入大腸桿菌DH5 α後,進行複製繁殖, 以酵素截切及聚合酵素連鎖反應的方式確認乳鐵蛋白cDNA 與表現載體接合成功與否及接合方向是否正確,並進行 D N A定序篩選出正確的乳鐵蛋白表現載體。乳鐵蛋白表現 載體送入DH5a大量複製後,抽取質體DnA以醋酸鋰(LiAc) 的方式將表現載體送入麵包酵母Sacch〇romyces cerevisiae 再以選擇性培養基MMC(minimal medium plate) 選尿σ密咬自營株(uracii aux〇tr〇phy)的酵母菌 株’挑出1 0到12個轉殖株後,同樣以含葡萄糖之MMC培養2 天後,將酵母菌沉澱下來,並以二次水洗掉葡萄糖,酵母 菌再培養於MMC以半乳糖取代葡萄糖,大約1 2〜1 8小時後收 下菌體並打破。以西方吸潰確認酵母菌内乳鐵蛋白的表 現,篩選帶有乳鐵蛋白的酵母菌株。 (三)· P i c h i a p a s t 〇 r i s表達乳鐵蛋白的純化 帶有乳鐵蛋白的Pichia pastoris經過兩天的培養 後,收集培養液並濃縮十倍,經西方吸潰確認確有乳鐵蛋 白,經過3 0到4 0 %硫酸銨沉澱,透析之後,經過 Sepharose-hepar i η 管柱的純化,經Ν端氨基酸序列分析Page 12 558565 V. Description of the invention (ίο) The expression vector composition includes the GAL1 promoter and the cytochrome-c-oxi (iase) CYCi termination sequence. It also reproduces the pig signal by polymerase chain reaction. Sequence and DNA fragment of mature porcine lactoferrin cDNA. This DNA fragment and expression vector are cut with SacI and then subjected to conjugation reaction. After transformation into E. coli DH5α, replication and reproduction are performed with enzyme cutting and polymerase chain reaction. The method was used to confirm whether the lactoferrin cDNA was successfully joined to the expression vector and whether the direction was correct, and DNA sequencing was performed to select the correct lactoferrin expression vector. The lactoferrin expression vector was sent to DH5a to replicate in large quantities, and plastid DnA was extracted. The expression vector was sent to baker's yeast Sacchromyces cerevisiae in the form of lithium acetate (LiAc), and then the urine strain σ was closely selected from the yeast strain of uracii auxotróphy using selective medium MMC (minimal medium plate). After picking up 10 to 12 transgenic plants, also cultivating them with glucose-containing MMC for 2 days, the yeast was precipitated, and the grapes were washed with secondary water The yeast was cultured in MMC to replace glucose with galactose, and the bacteria were collected and broken after about 12 to 18 hours. The performance of lactoferrin in the yeast was confirmed by Western blotting, and the yeast with lactoferrin was screened. Strains. (3) Purification of lactoferrin expressed by Pichiapast olis After cultivating Pichia pastoris with lactoferrin for two days, the culture solution was collected and concentrated ten times. Western blotting confirmed the presence of lactoferrin. After 30 to 40% ammonium sulfate precipitation, after dialysis, purification through a Sepharose-hepar i η column, and analysis of the N-terminal amino acid sequence

第13頁 558565 五、發明說明(π) 二維(2 - D )電 其N-端與豬乳乳鐵蛋白一樣。經與鐵結合及 冰/刀析的定性分析與-緒乳中乳鐵蛋白-樣。 鐵蛋白 2CDNA 序列;圖 2 為Pichia past〇ris 板進行聚合酵的構築示意圖;以PIGLTF質體作為模Page 13 558565 V. Description of the invention (π) Two-dimensional (2-D) electricity The N-terminus is the same as porcine lactoferrin. Qualitative analysis by iron binding and ice / knife analysis-lactoferrin-like in milk. Ferritin 2CDNA sequence; Figure 2 is a schematic diagram of the polymerase construction of Pichia pastolis plate; PIGLTF plastid was used as a model

端及3,端分別各’複製出約2.lkl^DNA片段,5, 過sfuI及XbaIi:^uI及XbaI辨識截切部位’與同樣經 戰切的pGAPZ B載體進行接合反應。 圖3顯示麵包酵母·· ^ 、 cerevisiae 中乳鐵蛋 ===載體的構築示意圖;以PIGLTF質體作為模板進行聚 素連鎖反應,複製出約2.ikb的DNA片段,5,端及3,端 都▼有SacI辨識載切部位,與同樣經過SacI截切的pYES2 載體進行接合反應。 圖4顯不以西方吸潰分析Pichia pastoris酵母菌株培養液 或細胞内重組乳鐵蛋白的表現結果;不同的轉形P i ch i a pas t oris酵母菌株細胞體經打破後離心取其上清液(A)或 培養液經10倍濃縮(B),分別以10% SDS-丙烯醯凝膠電泳 分析再轉潰到PVDF膜,以兔子抗豬乳鐵蛋白的抗血清Approximately 2.lkl of the DNA fragment were copied at the ends, 3, and 5, respectively, and 5, sfuI and XbaIi: ^ uI and XbaI identified the truncation site 'were subjected to a conjugation reaction with the same war-cut pGAPZ B vector. Figure 3 shows the construction of baker's yeast ..., cerevisiae lactoferrin eggs === vector; the PIGLTF plastid was used as a template to carry out the polymer chain reaction to copy the DNA fragment of about 2.ikb, 5, end and 3, Both ends have SacI to identify the cut site, and the splicing reaction with pYES2 vector also cut by SacI. Figure 4 shows the results of analyzing Pichia pastoris yeast strain culture medium or intracellular recombinant lactoferrin by Western suction; the cells of different transformed P i ch ia pas t oris yeast strains were centrifuged to obtain the supernatant. (A) or the culture solution was concentrated 10 times (B), and analyzed by 10% SDS-acrylic gel electrophoresis and then transferred to PVDF membrane, and rabbit anti-pig lactoferrin antiserum

第14頁 558565 五、發明說明(12) (rabbit ant i ~porc ^ ne lactoferrin polyclonal antibody)及接有過氧化酵素(peroxidase)的羊抗兔子免 疫球蛋白的抗體(HRP-conjugate goat anti-rabbit i p 進行西方吸潰的結果。mPLF代表由豬乳純化的乳鐵蛋白,) (-)代表沒有乳鐵蛋白CDNA的轉殖株。 ’Page 14 558565 V. Description of the invention (12) (rabbit ant i ~ porc ^ ne lactoferrin polyclonal antibody) and HRP-conjugate goat anti-rabbit ip with peroxidase-linked sheep anti-rabbit immunoglobulin antibody Results of Western sucking. MPLF stands for lactoferrin purified from pig milk, and (-) stands for transgenic strains without lactoferrin CDNA. ’

圖5顯示以西方吸潰分析麵包酵母菌Saccharomyces cerevisia酵母菌株細胞内重組乳鐵蛋白的表現;不同的 轉形麵包酵母菌Saccharomyces cerevisiae酵母菌株 (1 - 7 ),細胞打破後離心取上清液,以丨〇 % s D s _丙烯峻 膠電泳分析再轉潰到PVDF膜(Millipore),以兔子抗豬f 鐵蛋白的抗血清及接有過氧化酵素的羊抗兔子免疫球蛋礼 的抗體進行西方吸潰的結果。mPLF代表由豬乳純化的乳= 蛋白,(-)代表沒有乳鐵蛋白cDNA的轉殖株。 織 轉形酵母菌Pichia pastoris培養液以heparin親和性 管柱層析純化重組乳鐵蛋白及純化出的重組乳鐵蛋白的 SDS -丙烯酿凝滕電泳結果;培養液經過3〇 —4〇%硫酸銨沉澱 及透析後’通過heparin管柱以不同的鹽濃度梯度(〇· 2、 0 · 3、0 · 4、0 · 6 Μ氣化鈉)沖洗並收集,各個鹽濃度的收集 液以E L I S Α的方式測重組乳鐵蛋白的相對免疫性。〇 · 6 μ氣 化納的收集液部份以1 〇 % S D S -丙烯醯凝膠電泳分析如插圖(i 所示。mPLF代表由豬乳純化的乳鐵蛋白,M代表不同分子 量的蛋白質標準品由上至下分別為2〇〇、116、97、66、Figure 5 shows the expression of recombinant lactoferrin in the cells of Saccharomyces cerevisia yeast strains of baker's yeast by Western suction; different Saccharomyces cerevisiae yeast strains of different baker's yeast strains (1-7). The cells were centrifuged to obtain the supernatant.丨 〇% s D s _ acrylic gel electrophoresis analysis and then transferred to PVDF membrane (Millipore), rabbit anti-pig f-ferritin antiserum and peroxidase-containing sheep anti-rabbit immunoglobulin antibody The result of western suck. mPLF represents milk = protein purified from pig milk, and (-) represents transgenic strains without lactoferrin cDNA. Results of purification of recombinant lactoferrin by Heparin affinity column chromatography on the culture medium of Pichia pastoris of weaving transforming yeast and purified lactoferrin by SDS-propylene agglutination electrophoresis; the culture solution was subjected to 30-40% sulfuric acid After the ammonium precipitation and dialysis, it was washed and collected with different salt concentration gradients (0 · 2, 0 · 3, 0 · 4, 0 · 6 M sodium gasification) through a heparin column, and the collected solution of each salt concentration was ELIS Α To measure the relative immunity of recombinant lactoferrin. The collected portion of the 0.6 μN sodium vaporized solution was analyzed by 10% SDS-acrylic acid gel electrophoresis as shown in the illustration (i. MPLF represents lactoferrin purified from pig milk, and M represents protein standards of different molecular weights. From top to bottom: 200, 116, 97, 66,

558565 五、發明說明(13) -- 45、31及2 1 kDa。由結果可知重組乳鐵蛋白與豬乳乳鐵蛋 白的分子量相當。將‘純化所得重組乳鐵蛋白進行N端氨 基酸組成分析,結果顯示重組乳鐵蛋白N端丨〇個氨基酸1 成與豬乳乳鐵蛋白一樣。 & ° 圖7顯示由轉形酵母菌Pi Chi a past oris培養液中所純化後 的重組乳鐵蛋白’與鐵結合的吸收光譜;三價鐵與重組乳 鐵蛋白結合彳交在465 nm有最高的吸收值。插圖所示為UQ 到6 8 0 n m 的吸收圖譜。 實施例1 :豬乳腺c D N A庫的建立 以guanidium isothiocyanate 方法(參見Cathala, G 專人(1983) DNA,2,329-335)抽取大白豬的乳腺的所有細 胞内的RNA ’再以oligo (dT) - cellulose管柱層析分離出 Poly(A)+ RNA,以此分離出的Poly(A)+ RNA及經過Sfi I / Not I截切之lambda gtll載體作為構築⑼^庫的材料 來源,cDNA接至lambda gtl 1後組裝的噬菌體以大腸桿菌 Y 1 0 8 8 進行複製(參見 Sambrook, J·等人( 1 9 8 9 ) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.) o558565 V. Description of the invention (13)-45, 31 and 21 kDa. From the results, it was found that the molecular weight of the recombinant lactoferrin was equivalent to that of the pig lactoferrin. The N-terminal amino acid composition analysis of the purified recombinant lactoferrin showed that the N-terminal amino acid of the recombinant lactoferrin was the same as that of porcine lactoferrin. & ° Figure 7 shows the absorption spectrum of the recombinant lactoferrin 'bound to iron purified from the culture medium of Pi Chi a past oris of transforming yeast; the binding of ferric iron to the recombinant lactoferrin at 465 nm has The highest absorption value. The inset shows the absorption spectrum from UQ to 680 n m. Example 1: Establishment of porcine mammary g DNA library. The guanidium isothiocyanate method (see Cathala, G. (1983) DNA, 2, 329-335) was used to extract RNA from all cells of the mammary gland of large white pigs, followed by oligo (dT). -Poly (A) + RNA was separated by cellulose column chromatography, and the Poly (A) + RNA and lambda gtll vector cut by Sfi I / Not I were used as the material source for constructing the library. Bacteriophages assembled to lambda gtl 1 were replicated in E. coli Y 1 0 8 (see Sambrook, J. et al. (19 8 9) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.) O

實施例2 :由c D N A庫中篩選豬的乳鐵蛋白c D N AExample 2: Screening of pig lactoferrin c D N A from the c D N A library

第16頁 558565 五、發明說明(14) 〜 根據一般熟知的-方法進行豬的乳鐵蛋白cDNA的篩選 (Sambrook, J·等人(1989) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.) 。首先設計引 子:引子l(primerl):相當於核酸位置278 -297,及引子 2 :相當於核酸位置1 0 9 7 - 1 1 1 6,引子3 :相當於核酸位置 1044 - 1063,引子6:相當於核酸位置2333-2353,分別以引 子1/引子2及引子3/引子6為一組以聚合酵素連鎖反應的方 式複製出約為8 3 8及1 3 0 9鹽基對的DNA片段,以此DNA片段 進行α -【3 2 p】d C T P的放射性標定作為探針篩選豬乳腺 ¢, cDNA庫。篩選出的positive clones經過三次的筛選後以 聚乙二醇(polyethylene glycol)方法將噬菌體DNA抽出, 並將cDNA以Sfi I/Not I截切後接至PGEMIIZ ( —)載 體,命名為PLF3-1-2。將PLF3-1-2利用雙去氧終止定序法 由兩個方向進行定序,分析確定PLF3-1-2包含的豬乳鐵蛋 白cDNA序列由2 3 6 - 2 3 42。以總RNA進行反轉錄反應 (reverse transcription)後,以引子1及引子2進行聚合 酵素連鎖反應複製後,得到大約8 3 8鹽基對的D N A片段。將 此片段經Sma I切後接至pBluescript IIKS 載體,命名為 PLF5,經序列分析確定PLF5上接有豬乳鐵蛋白cDNA序列: 由1到838。全長的豬的乳鐵蛋ScDNA是將PLF3-1-2上的 Bgl n/HindHI片段接至PLF5上而得到的,命名為 PIGLTF(Wang,S. R·等人( 1 9 9 7 ) AJVR,58(10),Page 16 558565 V. Description of the invention (14) ~ Screening of porcine lactoferrin cDNA according to generally known methods (Sambrook, J. et al. (1989) Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor , NY: Cold Spring Harbor Laboratory Press.). First design primers: primerl (primerl): equivalent to nucleic acid positions 278 -297, and primer 2: equivalent to nucleic acid positions 1 0 9 7-1 1 1 6; primer 3: equivalent to nucleic acid positions 1044-1063, primer 6: Corresponding to nucleic acid positions 2333-2353, using primer 1 / primer 2 and primer 3 / primer 6 as a group to copy a DNA fragment of about 8 3 and 1 309 base pairs in a polymerase chain reaction manner, This DNA fragment was used to perform α- [3 2 p] d CTP radioactive calibration as a probe to screen porcine mammary gland cDNA library. The selected positive clones were screened by polyethylene glycol (polyethylene glycol) method after three screenings, and the cDNA was cut with Sfi I / Not I and then connected to the PGEMIIZ (—) vector, named PLF3- 1-2. The PLF3-1-2 was sequenced in two directions using the dideoxy termination sequencing method, and the sequence of the pig lactoferrin protein contained in PLF3-1-2 was determined to be 2 3 6-2 3 42. After reverse transcription reaction with total RNA, polymerase chain reaction with primer 1 and primer 2 for replication, a DNA fragment of about 8 3 8 base pairs was obtained. This fragment was cut with Sma I and then inserted into the pBluescript IIKS vector, named PLF5. Sequence analysis determined that the PLF5 was connected with the porcine lactoferrin cDNA sequence: from 1 to 838. The full-length pig lactoferrin ScDNA was obtained by connecting the Bgl n / HindHI fragment on PLF3-1-2 to PLF5, and named it PIGLTF (Wang, S.R. et al. (199 7) AJVR, 58 (10),

第17頁 558565 五、發明說明(15) 1 1 5 2 - 1 1 5 8 · )。P I G L T F經序列分析結果如圖1所示炎 鐵蛋白編碼區域(c 〇 di n g r e g i ο η )的核酸序列,共$ 1 的I 核酸,其可轉譯出豬的訊號序列及全長的豬乳鐵蛋 1 5個 實施例 3 : P i c h i a p a s t 〇 r i s 乳鐵蛋白表現載體的構# 的乳 如圖2所示,先以聚合酵素連鎖反應複製出諸 蛋白c D Ν Α片段,反應條件如下:以ρ I G L T F質體作為模I鐵 加入5’端及3,端的引子各0.5uM,〇·2πιΜ dNTP及最=板’ 叹、’尽遺疮 為1倍的反應緩衝液,5 U的p f u D N A 聚合酵素 人Page 17 558565 V. Description of the invention (15) 1 1 5 2-1 1 5 8 ·). The sequence analysis results of PIGLTF are shown in Figure 1. The nucleic acid sequence of the inflammatory ferritin coding region (c o di ngregi ο η), a total of $ 1 of the nucleic acid, which can translate the signal sequence of pigs and the full-length pig lactoferrin 1 5 Example 3: The milk of the structure # of Pichiapast olis lactoferrin expression vector is shown in FIG. 2. The protein c D Ν Α fragments are first copied by a polymerase chain reaction. The reaction conditions are as follows: The body was used as a mold I, and the 5 'end and the 3' end primers were 0.5uM each, 〇2πιM dNTP and the most = plate 'sigh,' repeated ulcer is 1 times the reaction buffer, 5 U pfu DNA polymerase human

(polymerase) ( Promega ),最後以去離子水調整使其最終 體積為5 0 u 1。 ^ 木 5,端的引子:5, -GCTTCGAACAAAACACAATGAAGCT CTTCATCCCCGCCCTGCTGTT-3,。 木 3’ 端的引子:5, 一GCTCTAGATTACCTCATCATGAAGGCACA-3, 5’端及3’端的引子各含有Sful及Xbal限制酵素可辨識的位 置。聚合酵素連鎖反應條件為先以9 4 t加熱2分鐘,再進 行3 0個增殖循環,每個循環包括9 4 °C,3 0秒、5 7 °C,4 0秒、 72 °C,4.5分,最後在72°C反應10分鐘。聚合酵素連鎖反應 完成後,把所有的反應物加入最終濃度為1倍的D N A分析染 劑’以1 %的遵酯糖電泳(a g a r 〇 s e g e 1 )内含溴化乙基淀 (ethidium bromide)進行分析,並以商業合成之DNA片段 為分子量標誌,切下大約2 · 1 k b大小的複製片段,再以商 業的回收套組(Viogene),將此DNA沖洗出來,最後溶於二(polymerase) (Promega), and finally adjusted with deionized water to a final volume of 50 u 1. ^ Wood 5, end primer: 5, -GCTTCGAACAAAACACAATGAAGCT CTTCATCCCCGCCCTGCTGTT-3 ,. Primers at the 3 ′ end of the wood: 5, a GCTCTAGATTACCTCATCATGAAGGCACA-3, 5 ′ and 3 ′ end primers each contain positions recognizable by Sful and Xbal restriction enzymes. The polymerase chain reaction conditions are: first heating at 9 4 t for 2 minutes, and then performing 30 proliferation cycles, each cycle including 94 ° C, 30 seconds, 5 7 ° C, 40 seconds, 72 ° C, 4.5 Minutes, and finally reacted at 72 ° C for 10 minutes. After the completion of the polymerase chain reaction, all the reactants were added to the DNA analysis dye at a final concentration of 1 ', and the electrophoresis was performed with 1% azidose bromide containing ethidium bromide. Analyze and use commercially available DNA fragments as molecular weight markers. Cut out approximately 2.1 kb copies, and then use a commercial recovery kit (Viogene) to wash out the DNA and dissolve it in

第18頁 558565 五、發明說明(16) 人水中。取少量D N A再以緩酯糖電泳確認一次d n A的大小及 純度’將上述聚合酵-素連鎖反應複製並純化後之乳鐵蛋白 c D N A片段的產物,加入最終濃度一倍的酵素反應緩衝液和 限制酵素Sful及Xbal放置於37 °C水浴槽,酵素反應時間為 1〜2小時,同時表現載體pGApz.B (Invitr〇gen)也以sful 及X b a I截切。表現載體並以瓊酯糖膠確認截切反應完全與 否,切下反應完全之線性表現載體片段並沖洗出來,再與 同樣經過酵素反應並經純化的乳鐵蛋白c D N A片段混合,加 入連接酵素(T4 DNA ligase,Promega)在16。(:下反應16小 時,再置於4 °C 1〜4小時,把連接反應物使用習知的方法 (Molecular cloning- A Laboratory Manual; Cold ψ Spring Harbor,1989)送入大腸桿菌DH5 α的勝任細胞 (Promega)。以含有 Zeocine (Invitrogen)的低鹽 LB 培 養盤(1% tryptone,0·5%氯化鈉,0.5% 酵母萃取物 (yeast extract) ’1.5% 洋菜膠)篩選轉形成功的菌株。 將具有Zeocine抗性的菌株培養在3毫升的低鹽LB培養液 (含25ug/ml Zeocine)經37 °C震盪培養12-16小時後,抽取 質體D N A以限制酵素S f u I / X b a I確認截切後,認表現載 體DNA有2.1k鹽基對的插入DNA,再將此表現載體DNA進行 序列分析。序列分析的部位包含GAP啟動子與乳鐵蛋白 cDNA的連接處及乳鐵蛋白cDNA與A0X1終止序列的連接處及 全長的乳鐵蛋白cDNA。篩選出正確的表現載體將其命名為 PLF °Page 18 558565 V. Description of the invention (16) Human water. Take a small amount of DNA and confirm the size and purity of dn A by slow ester sugar electrophoresis. 'The product of the lactoferrin c DNA fragment copied and purified from the polymerase-enzyme chain reaction described above was added to the enzyme reaction buffer at twice the final concentration. The restriction enzymes Sful and Xbal were placed in a 37 ° C water bath, and the enzyme reaction time was 1 to 2 hours. At the same time, the expression vectors pGApz.B (Invitrogen) were also cut with sful and X ba I. Express the carrier and confirm the completeness of the truncation reaction with agarose gel. Cut the linear expression carrier fragment that has completed the reaction and rinse it out. Then mix with the purified lactoferrin c DNA fragment that has also undergone the enzyme reaction and add the ligation enzyme. (T4 DNA ligase, Promega) at 16. (: 16 hours under reaction, and then placed at 4 ° C for 1 to 4 hours. The ligation reaction was sent to E. coli DH5α using a conventional method (Molecular cloning- A Laboratory Manual; Cold ψ Spring Harbor, 1989). Cells (Promega). Low-salt LB culture plates (1% tryptone, 0.5% sodium chloride, 0.5% yeast extract '1.5% agar gelatin) containing Zeocine (Invitrogen) were successfully transformed. The strain with Zeocine resistance was cultured in 3 ml of low-salt LB broth (containing 25ug / ml Zeocine) and cultured at 37 ° C with shaking for 12-16 hours, then the plastid DNA was extracted to limit the enzyme S fu I / After X ba I confirmed the truncation, it was confirmed that the expression vector DNA had 2.1k base-pair inserted DNA, and then the expression vector DNA was subjected to sequence analysis. The sequence analysis site included the junction between the GAP promoter and lactoferrin cDNA and milk The junction of ferritin cDNA and A0X1 termination sequence and the full-length lactoferrin cDNA. Screen the correct expression vector and name it PLF °

第19頁 558565 五、發明說明(17) 貫施例4 :緒乳鐵蛋白在P i c h i a p a s t 〇 r i s的表現 表現載體PLF以Avr Π酵素在37 °C反應卜2小時,取少 量D N A以瓊醋膠體分析確定線性化完全後,將此線性化乳 鐵蛋白表現載體DNA以酚/氣仿(25 : 2 4 )萃取,純化後溶於 二次水並以電脈衝(616(::1:1*〇1^(^3 1^〇11)(£01^600,3丁乂)的 方式送入蛋白酵素(protease)具有缺陷的Pichia pastoris SMD1168菌株,再以含不同濃度Zeocine的YPD (1% peptone,2%酵母菌萃取物,2%葡萄糖,2% 洋菜膠) 培養盤(100叩、50〇1^、111^、2111运/111126〇(^116)_選轉殖 株。經過在丫?0/26〇〇丨116培養盤30^:3-4天的培養後,挑選| 具Zeocine抗性的轉殖株,培養在5毫升的ypd 培養液經二 天30°C 250rpm的震盪培養,收下菌液並以3〇〇〇rpin離心10 分鐘分開培養液與菌體,培養液以離心的方式濃縮 (Amicon plus)約10倍,菌體溶於等體積breaking buffer(50mM NaH2P04 , ImM PMSF , ImM EDTA , 5% 甘油) 及等體積的玻璃珠(425-600um,Sigma)經過5到10次1分鐘 的震盈(vortex)打破後,以i3〇〇〇rpm離心10分鐘後,取上 清液加入等體積的樣品緩衝溶液(62.5 mM Tris-HCl,pH 6·8 ’25% 甘油,2% SDS,〇·〇1% Bromophenol Blue)在非 還原(non-reducing)的條件下以1 0-12% SDS-丙烯醯凝膠 _ 電泳分析’以半乾(s e m i - d r y ) ( B i ο _ r a d )的方法轉潰到 Hybon-C -硝化纖維素薄膜(nitrocellulose membrane) 後’以含有1 %牛血清白蛋白(B S A )的磷酸鹽緩衝溶液Page 19 558565 V. Description of the invention (17) Implementation Example 4: The expression of lactoferrin in Pichiapastoris. The carrier PLF was reacted with Avr Π enzyme at 37 ° C for 2 hours, and a small amount of DNA was taken to agar acetate colloid. After the analysis confirms that the linearization is complete, the linearized lactoferrin expression carrier DNA is extracted with phenol / aeroform (25: 2 4), purified and dissolved in secondary water and subjected to electrical pulses (616 (:: 1: 1 * 〇1 ^ (^ 3 1 ^ 〇11) (£ 01 ^ 600, 3 butyl) was fed into Pichia pastoris SMD1168 strain with defective protease, and then YPD (1% peptone) with different concentrations of Zeocine , 2% yeast extract, 2% glucose, 2% agar gelatin) culture plate (100 叩, 501 叩, 111 ^, 21112 / 111126〇 (^ 116) _selected transgenic plants. 0 / 26〇 丨 116 culture plate 30 ^: After 3-4 days of culture, select | Zeocine-resistant transgenic plants, culture in 5 ml of ypd medium and shake culture at 250 ° C and 30 ° C for two days, The bacterial solution was collected and centrifuged at 3000 rp for 10 minutes to separate the culture solution from the bacterial cells. The culture solution was concentrated by centrifugation (Amicon plus) about 10 times, and the bacterial cells were dissolved in the isosome. The volume of the breaking buffer (50mM NaH2P04, ImM PMSF, ImM EDTA, 5% glycerol) and the same volume of glass beads (425-600um, Sigma) were broken by 5 to 10 1-minute vortex breaks, and then i30. After centrifugation at 0 rpm for 10 minutes, the supernatant was added to an equal volume of sample buffer solution (62.5 mM Tris-HCl, pH 6.8 '25% glycerol, 2% SDS, 0.001% Bromophenol Blue) in a non-reducing ( under non-reducing) conditions with 10-12% SDS-acrylic acid gel _ electrophoretic analysis' Semi-dry (B i ο _ rad) method to transfer to Hybon-C-nitrocellulose Membrane (nitrocellulose membrane) with phosphate buffer solution containing 1% bovine serum albumin (BSA)

第20頁 558565 五、發明說明(18) (phosphate-buffered saline)進行隔夜的blocking,再 加入兔子抗豬乳鐵蛋—白的抗血清以?£51'(?“/05〇/〇Page 20 558565 V. Description of the invention (18) (phosphate-buffered saline) Block overnight, then add rabbit anti-pig lactoferrin-white antiserum? £ 51 '(? "/ 05〇 / 〇

Tween20)稀釋2000倍在室溫反應1-2小時後,以PBST清洗5 分鐘重複三次過後,再加入純化的羊抗兔子免疫球蛋白的 抗體’此抗體連接有過氧化酵素(以pBST稀釋2〇〇〇倍),同 樣在室溫反應卜2小時,以PBST清洗5分鐘重複三次過後, 再DAB(diaminobenzidine)進行呈色反應,圖4顯示培養液 及細胞萃取物(A )中皆有豬乳鐵蛋白的表現。表示豬的 訊號序列可被pichia pastoris辨識,因此合成的豬乳鐵 蛋白可被分泌至細胞外。 二^例5:製備酵母菌(Pichia pastoris)帶有乳鐵蛋白及Tween20) diluted 2000-fold and reacted at room temperature for 1-2 hours. After washing with PBST for 5 minutes, the reaction was repeated three times, and then purified goat anti-rabbit immunoglobulin antibody was added. This antibody was linked with a peroxidase (diluted with pBST 2). 〇〇 倍), the same reaction at room temperature for 2 hours, washed with PBST for 5 minutes and repeated three times, and then DAB (diaminobenzidine) color reaction, Figure 4 shows that culture medium and cell extract (A) pig milk The performance of ferritin. The signal sequence representing pigs can be recognized by pichia pastoris, so the synthetic porcine lactoferrin can be secreted extracellularly. Example 2: Preparation of yeast (Pichia pastoris) with lactoferrin and

化鐵形酵母菌(PiChia PaSt〇ris)培養在YPD及〇 — lmM氯 到3天eCl3)的培養基中,在30°c以250rpm震盪培養大約2 所得的’收主下菌液並分開菌體與培養液,菌體打破後離心 贫:μ上清液及培養液濃縮1 0倍,分別以西方吸潰法確定 鐵似乎Γ日的表現’結果顯示在0-100uM氣化鐵的條件下 較強7可輪微的促進酵母菌的生長’且西方吸潰的訊號比 ^對的而鐵濃度大於5 0 0 u M以後則會抑制酵母菌的生長’ 氣化鐵西方吸潰的訊號比較弱。因此可以以含有0 —10 0 u M 母菌在V的YPD培養液製備帶有乳鐵蛋白及鐵的酵母菌。酵 P D (或含氣化鐵)培養液經2 - 3天的培養到生長飽和The fermented yeast (PiChia PaStoris) was cultured in YPD and 0-1 mM chlorine to 3 days eCl3), and the culture solution was shaken and cultured at 30 ° C and 250 rpm for about 2 hours. Centrifugation was depleted with culture medium and bacterial cells after centrifugation: μ supernatant and culture medium were concentrated 10 times, and the performance of iron seemed to be determined by Western blotting method. The results showed that compared with 0-100uM iron gasification Strong 7 can slightly promote the growth of yeasts, and the signal of western absorption is better. The iron concentration of more than 500 u M will inhibit the growth of yeast. The signal of western absorption of gasified iron is weak. . Therefore, yeasts with lactoferrin and iron can be prepared from YPD broth containing 0-10 0 u M mother bacteria in V. Fermentation P D (or gaseous iron-containing) broth after 2 to 3 days of cultivation to growth saturation

第21頁 558565 五、發明說明(19) 時期,可直接回收菌液(菌體加培養液),因為培養液中也 帶有乳鐵蛋白,且酵-母菌體及其培養液共同做為飼料添 加’將可增加動物的育成率。也可以只回收菌體做為飼料 添加的製備。 實施例6: 麵包酵母菌(Saccharonyces cerevisiae)乳鐵 蛋白 表現載體的構築 如圖3所示以聚合酵素連鎖反應複製豬的乳鐵蛋白 cDNA片段,引子的設計如下: 5’ 端引子:5, -ACGAGCTCTAAAC.AAAATGAAGCTCTT ψ CATCCCCGCCCTGCTGTT-3’ °Page 21 558565 V. Description of the invention (19) Period, the bacterial liquid (bacterial body plus culture liquid) can be directly recovered, because the culture liquid also contains lactoferrin, and the yeast-mother body and its culture liquid are used together The addition of feed will increase the breeding rate of the animal. It is also possible to recover only the bacterial cells as a feed addition preparation. Example 6: Construction of a bacteriophage (Saccharonyces cerevisiae) lactoferrin expression vector As shown in FIG. 3, a pig lactoferrin cDNA fragment was replicated using a polymerase chain reaction. The primer design was as follows: 5 'end primer: 5,- ACGAGCTCTAAAC.AAAATGAAGCTCTT ψ CATCCCCGCCCTGCTGTT-3 '°

3’ 端引子:5’ -ACGAGCTCTTACCTCATCATGAAGGCACAGG CTT-3’ ° 5’及3’端引子都帶有SacI的辨識截切部位。聚合酵素連 鎖反應產物以1 % 瓊酯糖膠體分析,並切下含2 . 1 k鹽基對 DNA片段的膠體,以回收套組(Viogene)將DNA沖洗下來 後,以限制酵素SacI在37 °C進行截切,同時表現載體YES 2 也以Sac I進行截切,反應後的YES2及乳鐵蛋白cDΝΑ片段經 純化後進行接合反應,並轉形到DH 5 α (參考實施例3 ), 篩選幾株D Η 5 α菌株進行質體的製備與確認,並進行序列 分析,將正確帶有豬的乳鐵蛋白cDNA的質體命名為YLF。 Β 貫施例7:豬乳鐵蛋白在麵包酵母菌(Saccharomyces3'-end primer: 5'-ACGAGCTCTTACCTCATCATGAGAGCACAGG CTT-3 '° 5' and 3'-end primers carry SacI recognition truncation sites. The polymerase chain reaction product was analyzed with 1% agarose colloid, and the colloid containing 2.1 k base pairs of DNA fragments was excised, and the DNA was washed down by a recovery kit (Viogene) to limit the enzyme SacI at 37 °. C was cut, and the expression vector YES 2 was also cut with Sac I. After the reaction, the YES2 and lactoferrin cDNA fragments were purified and then subjected to the splicing reaction, and transformed to DH 5 α (Reference Example 3). Several D Η 5 α strains were prepared and confirmed for plastids, and sequence analysis was performed. The plastids that correctly carried pig lactoferrin cDNA were named YLF. Β Implementation Example 7: Saccharomyces porcine lactoferrin

第22頁 558565 五、發明說明(20) cerevisiae)的表現 將YLF質體以LiAc的方式(Ito,H.等人(1 9 8 3 )厂 Bacteriol.,153 :163-186)轉形到蛋白酵素具有缺陷的麵 包酵母Saccharonyces cerevisiae 菌株,此菌株必須在 可提供白胺酸(leucine)、尿嘧啶(uraci 1 )及色胺酸 (tryptophan)的培養條件下才能生長,表現載體具有尿嘧 的篩選標記,因此可以篩選尿哺自營株(auxotrophy)的轉 殖株,以缺乏尿嘧的選擇性培養基MMC (0.67% yeast nitrogen base ,0·5% casam i no acid ,2% 葡萄糖, 0 · 0 2 % 白胺酸,〇 · 〇 〇 2 °/。色胺酸,2 % 洋菜膠)篩選轉殖 < 株,轉形後的菌液在Μ M C培養皿中經3 - 4天的3 0 °C培養液, 挑出幾個菌株作為模板進行菌落直接聚合酵素連鎖反應 (colony direct PCR)(Trower,Μ·Κ·等人( 1 9 9 6 ) MethodsPage 22 558565 V. Description of invention (20) cerevisiae) The YLF plastid was transformed into protein in the manner of LiAc (Ito, H. et al. (19 8 3) Plant Bacteriol., 153: 163-186) Bacteria yeast Saccharonyces cerevisiae strains with defective enzymes. This strain can only grow under culture conditions that can provide leucine, uracil 1 and tryptophan. The expression vector has uracil screening. Markers, so it is possible to screen auxotrophy transgenic plants in a selective medium lacking uracil MMC (0.67% yeast nitrogen base, 0.5% casam i no acid, 2% glucose, 0 · 0 2% leucine, 0.002 ° /. Tryptophan, 2% agar gum) Screening of the transgenic < strain, the transformed bacterial solution was cultured in a MC dish for 3 to 4 days. 0 ° C culture medium, several strains were selected as templates for colony direct polymerase chain reaction (colony direct PCR) (Trower, M.K. et al. (196))

Mol· Biol·,58, 329-333),以引子8相當於編碼區域的 1 2 8 6 - 1 3 1 8的核酸序列及引子LF3相當於編碼區域的 2090-2115的核酸序列進行聚合酵素連鎖反應,以μ$ 分鐘破壞細胞,再進行30個增殖循環,每個"循環包括Μ °C>1分、分、72°C,2分,最後再72。(:反應10分鐘, 將聚合酵素連鎖反應產物以丨%瓊酯糖膠體分析,確認酵 ί Ϊρ中二蛋白CDNA的存在,聚合酵素連鎖反應反應 中以PIGLTF質體作為正對照組(p〇siUve ,可複 製出大約800鹽基對的dna片段,令人缺表主 1 Θ I® Μ — & 的 ♦合酵素連鎖反應的結果 為正反應的囷株,將其培養在MMC培養液兩天後,收下菌Mol · Biol ·, 58, 329-333), polymerase linked with a nucleic acid sequence of primer 8 corresponding to the coding region 1 2 8 6-1 3 1 8 and primer LF3 nucleic acid sequence corresponding to the coding region 2090-2115 In the reaction, the cells were destroyed in μ $ minutes, and then 30 cycles of proliferation were performed, each "cycle including M ° C> 1 minute, minute, 72 ° C, 2 minutes, and finally 72 minutes. (: Reaction for 10 minutes, the polymerase chain reaction product was analyzed with 丨% agarose colloid to confirm the presence of the secondary protein CDNA in the enzyme, PIGLTF plastid was used as a positive control group in the polymerase chain reaction (p〇siUve The DNA fragment of about 800 base pairs can be reproduced, causing the lack of the main host 1 Θ I® M — & The result of the synthase chain reaction is a positive strain, which is cultured in MMC culture solution for two days After receiving the bacteria

558565 五、發明說明(21) 液並以3 0 0 0 r pm離心1 0分鐘分開培養液及菌體,菌體以二 次水洗兩次後,再加_以2°/。半乳糖取代2%葡萄糖的MMC (半 乳糖)培養液繼續培養,以半乳糖取代葡萄糖的目的是活 化啟動子GAL1啟動子,進而帶動乳鐵蛋白基因的表現,經 1 2〜1 8小時的培養後收下菌液並離心,分開培養液與菌 體,菌體以玻璃珠打破,經離心取上清液部份稱為細胞萃 取物。將細胞萃取物在非還原的條件下以1 0〜1 2 °/◦的S D S -丙 稀醢凝膠電泳分析並轉潰到H y b ο η - C -硝化纖維素薄膜 (nitrocellulose membrane ),以兔子抗緒鐵蛋白的抗 血清及純化的羊抗兔子免疫球蛋白I gG的抗體(此抗體連接 過氧化酵素)進行西方吸潰的分析(參考實施例4)。結果如4 圖5所示隨機篩選的菌株(1-7)菌體内都有乳鐵蛋白的表 現’但在培養液中無法偵測到乳鐵蛋白的存在,表示豬的 訊號序列無法被麵包酵母菌(Saccharomyces cerevisiae) 辨識’因此合成的豬乳鐵蛋白無法被分泌至細胞外。 貝施例8:製備麵包酵母菌(sacchar〇myces cerevisiae)帶 有乳鐵蛋白558565 V. Description of the invention (21) solution and centrifugation at 3, 000 r pm for 10 minutes to separate the culture solution and the bacterial cells. After the bacterial cells were washed twice with water twice, _ was added to 2 ° /. Galactose replaced 2% glucose in MMC (galactose) culture medium. The purpose of replacing galactose with glucose is to activate the promoter GAL1 promoter, which in turn drives the expression of the lactoferrin gene. After 12 to 18 hours of culture The bacterial solution was collected and centrifuged to separate the culture solution from the bacterial cells. The bacterial cells were broken with glass beads. The supernatant was centrifuged to obtain the cell extract. The cell extract was analyzed under non-reducing conditions by 10 to 12 ° / ◦ SDS-acrylic gel electrophoresis and transferred to Hyb ο η-C-nitrocellulose membrane. Rabbit anti-ferritin antiserum and purified goat anti-rabbit immunoglobulin I gG antibody (this antibody is linked to a peroxidase) were analyzed for Western blotting (see Example 4). The results are shown in Figure 4 and Figure 5. Randomly screened strains (1-7) have lactoferrin expression in their cells', but the presence of lactoferrin cannot be detected in the culture medium, indicating that the pig's signal sequence cannot be breaded Yeast (Saccharomyces cerevisiae) recognizes' so synthetic porcine lactoferrin cannot be secreted extracellularly. Example 8: Preparation of baker's yeast (saccharomyces cerevisiae) with lactoferrin

如圖5所示菌體内都有乳鐵蛋白的表現,但在培養液 中無法偵測到乳鐵蛋白的存在,表示在麵包酵母菌 CSacchairomyces cereviSiae)無法辨識豬的訊號序列,因 此雖然細胞内有乳鐵蛋白的合成但卻無法釋放出來。此結 果並不影響酵母菌帶有乳鐵蛋白的製程,因為菌體内都有As shown in Figure 5, lactoferrin is present in the bacteria, but the presence of lactoferrin cannot be detected in the culture medium, which indicates that the signal sequence of pigs cannot be recognized in the bread yeast CSacchairomyces cereviSiae. Lactoferrin is synthesized but cannot be released. This result does not affect the process of yeast with lactoferrin, because

第24頁 558565Page 558565

五、發明說明(22) 乳鐵蛋白。將麵包酵母菌(S ▼ —、- accharomyces cerevisia^x 選擇性=養MMC培養液經卜3天的培養後,離心收集菌體乂 以一人去離子水洗掉殘留的葡萄糖,再以半乳糠 萄糖誘導乳鐵蛋白表現,在含有半乳糖的選擇性培養MM(^ 培養液繼續培養1 2 - 1 8小時後,直接離心回收菌體或以菌 液(菌體加培養液)作為飼料添加的製備。 實施例9 : P 1 c h i a p a s t 〇 r i s表現乳鐵蛋白的純化 純化乳鐵蛋白的方法參考Chu, L. F·等人(1993)V. Description of the invention (22) Lactoferrin. After baker's yeast (S ▼ —,-accharomyces cerevisia ^ x selectivity = cultured MMC culture solution was cultured for 3 days, the bacteria were collected by centrifugation, and the remaining glucose was washed with deionized water by one person, and then galacin bran was used. Lactose-induced lactoferrin expression. After selective culture of MM containing galactose (^ Continue to incubate the culture medium for 12 to 18 hours, directly recover the bacterial cells by centrifugation or add the bacterial solution (bacterial cells plus culture solution) as feed. Example 9: Purification of lactoferrin by P 1 chiapast olis. For the method of purifying lactoferrin, refer to Chu, L. F. et al. (1993)

Am· J· Vet· Res· 54, 1 1 54 - 1 1 5 8.。將 GLF1 培養在 2 5 0 毫 4 升的YPD,經隔夜30°C的培養後再以新鮮的YPD培養液稀釋 1 0 0〜2 0 0倍,繼續培養2天後,收下培養液並離心收集上清 液’將上清液以3 0 - 4 0 %硫酸錄沉殿後,以5 m Μ T r i s ( p Η 7. 9)將此沉澱物溶解,以透析膜(MWCO : lOkD)進行透析後, 將樣品以Heparin-Sepharose管柱進行層析,以0.2到0.6M 氣化鈉進行非連續性梯度(step-gradient)的分離。將各 個不同鹽濃度所收集的沖洗液,以EL I S A的方式測其重組 乳鐵蛋白的相對免疫性,重組乳鐵蛋白大約在0. 6 Μ氣化鈉 的條件下會被沖洗下來,將沖洗下來的重組乳鐵蛋白以 SDS-丙烯醯凝膠電泳分析其純度,並轉潰到PVDF膜 (Millipore)以amido black染色後裁下乳鐵蛋白的部份,· 進行氨基端的序列分析。分析結果確認其氨基端十個氨基 酸序列與豬乳中之乳鐵蛋白一樣。Am · J · Vet · Res · 54, 1 1 54-1 1 5 8. GLF1 was cultured at 250 milliliters of 4 liters of YPD. After overnight culture at 30 ° C, it was diluted with fresh YPD culture solution 100- to 200-fold. After 2 days of incubation, the culture solution was collected and centrifuged. Collect the supernatant 'After collecting the supernatant with 30-40% sulfuric acid, dissolve the precipitate with 5 μM Tris (p Η 7. 9) and dialyze with a dialysis membrane (MWCO: 10kD). Then, the sample was chromatographed on a Heparin-Sepharose column, and step-gradient separation was performed with 0.2 to 0.6 M sodium gaseous phase. The washing liquid collected at different salt concentrations was measured for the relative immunity of the recombinant lactoferrin by the EL ISA method. The recombinant lactoferrin will be washed down under the condition of about 0.6 M sodium gaseous solution. The purified recombinant lactoferrin was analyzed for its purity by SDS-acrylic acid gel electrophoresis, and transferred to a PVDF membrane (Millipore) and stained with amido black to cut out the lactoferrin portion, and perform sequence analysis of the amino terminus. The analysis results confirmed that the amino acid ten amino acid sequence was the same as that of lactoferrin in pig milk.

第25頁 558565 五、發明說明(23) 實施例1 0 : 重組乳鐵-蛋白與鐵的結合 重組乳鐵蛋白與鐵的結合的方法參考Chu, L. F· 等 人( 1 9 9 3 ) Am· J· Vet· Res· 54, 1 1 54 - 1 1 5 8。將純化的 重組乳鐵蛋白溶於鐵結合緩衝溶液(25mM Tr is ρΗ7· 5、 10mM NaHC03 、0·1Μ氯化鈉、lOOuM氯化鐵)並於37°C反應 30分鐘後,以Bio-gel P-6 column除去未與重組乳鐵蛋白 結合的三價鐵離子),將此重組乳鐵蛋白以分光光譜儀 (spectrophotometer)測其350至700nm的吸收圖譜,結果 如圖7所示在4 6 5 n m有一吸收值且與豬乳中之乳鐵蛋白比 丨 較其圖譜是一樣的。 實施例1 1 : E L I S A分析純化重組乳鐵蛋白 取氣化鈉鹽梯度沖洗下來的各個沖洗液各丨〇 〇 u 1,吸 附到96孔洞盤30分鐘後,以PBST(pBS/〇 〇5% Tweerl 20) Φ 洗三次各5分鐘,加入兔子抗豬乳鐵蛋白的抗血清(以pBST 稀釋2 0 0 0倍)反應1-2小時,以pBST洗三次各5分鐘,再加 入及純化的羊抗兔子免疫球蛋白IgG的抗體(以pBST稀釋 2^0 0 0倍)’此抗體連接過氧化酵素反應卜2小時,以pBST洗 三次各5分鐘’加入TMB過氧化酵素基質(Kirkeguard an(i P一erry Laboratories)呈色,測其63〇nm吸收值,如圖6所 不在〇· 6M氯化鈉的收集液具有最高值,取最高值的幾個收P.25 558565 V. Description of the invention (23) Example 10: Recombination of recombinant lactoferrin-iron with iron Refer to Chu, L. F. et al. (1 9 9 3) Am · J · Vet · Res · 54, 1 1 54-1 1 5 8 The purified recombinant lactoferrin was dissolved in an iron-binding buffer solution (25mM Tris ρ7.5, 10mM NaHC03, 0.1M sodium chloride, 100uM iron chloride) and reacted at 37 ° C for 30 minutes, followed by Bio-gel P-6 column removes the trivalent iron ions that are not bound to the recombinant lactoferrin). This recombinant lactoferrin was measured with a spectrophotometer and its absorption spectrum was 350 to 700 nm. The results are shown in Figure 7 at 4 6 5 nm has an absorption value and is the same as the lactoferrin ratio in pig milk. Example 11: Purification of recombinant lactoferrin by ELISA analysis. Each washing solution washed with a gaseous sodium salt gradient was washed with oooo1. After being adsorbed to a 96-well plate for 30 minutes, PBST (pBS / 005% Tweerl) was used. 20) Φ Wash three times for 5 minutes each, add rabbit anti-pig lactoferrin antiserum (diluted 2000 times with pBST) and react for 1-2 hours, wash three times with pBST for 5 minutes each, then add and purify the goat antibody Rabbit immunoglobulin IgG antibody (diluted 2 ^ 0 0 0 times with pBST) 'This antibody is linked to a peroxidase reaction for 2 hours, washed three times with pBST for 5 minutes each' and added a TMB peroxidase substrate (Kirkeguard an (i P Erry Laboratories) color, measured its absorption value at 63nm, as shown in Figure 6. The collection solution of 0.6M sodium chloride has the highest value, taking the highest value

第26頁 5585,65 五、發明說明(24) 集液以S D S -丙烯醯凝膠電泳分析,由圖6的插圖可確定重 組乳鐵蛋白在0 . 6 Μ氯-化鈉的收集液相當純且分子量與豬乳 乳鐵蛋白相當,以此純化的重組乳鐵蛋白進行定性分析。 依照前述,本發明提供兩個包括豬乳鐵蛋白之c D Ν Α編 碼區域的重組性質體,這兩個重組性質體可被用於轉形酵 母菌中表現,將可使酵母菌帶有豬乳鐵蛋白。 又,本發明提供兩種可供重組性質體轉形之酵母 菌,該兩種重組性質體一包含質體型表現載體或另一包含 嵌入型表現載體,該兩種重組性質體都嵌有一段豬乳鐵蛋f 白之c D Ν A編碼區域。 再者,本發明亦提供生產帶有重組豬乳鐵蛋白的酵母 菌的方法,該方法包括培養帶有重組質體的酵母菌,該重 組質體包含質體型表現載體或包含嵌入型表現載體,都嵌 有一段豬乳鐵蛋白之cDNA編碼區域。在一合適的營養培養 基中培養該酵母菌,由培養液中分離該重組乳鐵蛋白,其 生化特性與豬乳乳鐵蛋白一樣。 本發明可提供一種直接以酵母菌或以酵母菌培養液作 為乳鐵蛋白及鐵的攜帶者,將乳鐵蛋白及鐵加入飼料中防 止仔緒貧血下痛1的發生,提高仔豬育成率的方法。此帶有 重組豬乳鐵蛋白的酵母菌也可以作為健康食品的成分之Page 26 5585, 65 V. Description of the invention (24) The collected liquid was analyzed by SDS-acrylic acid gel electrophoresis. The inset of Fig. 6 can confirm that the collected liquid of the recombinant lactoferrin was quite pure at 0.6 M sodium chloride. And the molecular weight is equivalent to porcine milk lactoferrin, and the purified recombinant lactoferrin is used for qualitative analysis. According to the foregoing, the present invention provides two recombinant protoplasts including the c D Ν Α coding region of porcine lactoferrin, and these two recombinant protoplasts can be used for expression in transformed yeasts, which will allow yeasts to carry pigs. Lactoferrin. In addition, the present invention provides two yeasts that can be transformed by recombinant protoplasts. One of the two recombinant protoplasts includes a plastid-type performance vector or the other includes an embedded-type performance vector. Lactoferrin egg f white c D Ν A coding region. Furthermore, the present invention also provides a method for producing a yeast with recombinant porcine lactoferrin, the method comprising culturing a yeast with a recombinant plastid, the recombinant plastid comprising a plastid-type expression vector or an embedded expression vector, Both are embedded with a cDNA encoding region of porcine lactoferrin. The yeast is cultured in a suitable nutrient medium, and the recombinant lactoferrin is isolated from the culture medium, and its biochemical characteristics are the same as that of porcine lactoferrin. The invention can provide a method for directly using yeast or yeast culture liquid as a carrier of lactoferrin and iron, and adding lactoferrin and iron to feed to prevent the occurrence of analgesia 1 in piglets and increase the growth rate of piglets. . This yeast with recombinant porcine lactoferrin can also be used as an ingredient in health foods

第27頁 558565 五、發明說明(25)Page 27 558565 V. Description of the invention (25)

I1HI 第28頁I1HI Page 28

Claims (1)

558565 /々· -.1?·^ 贫本 六、申請專利範圍 申請專利範圍: 1. 一 種麵包酵母菌(Saccharomyces cerevisiae )YES15(CCRC 9403 10),其包括一質體YLF,該質體包含編 碼豬乳鐵蛋白的聚去氧核醣核酸(c D N A )的序列如下: ATGAAGCTCT TCATCCCCGC CCTCCTGm CTCTGGACAC nGGACTGTG TCTCaTCrCC 60 CCTk\Q^\G CCOTTCGATG GTGTGTCATA TCCACACCAG AGTAHC.UA ATCCCCTCAG 120 TGGC.A.ATaA AGATMGAAG MCT.^ATCCC ATCTTCTGCA UAC<}AGGGC nCTCCCACT 180 GACTGTATCC GGGCCATCGC GGCAA.\AAGG GCAGATGCTG TGACCCITGA TGGTGGTITG 240 GTGTTTC.^G CAGCCCAGTA CUACTGCGG CCGGTAGCAG CGGAGATCTA CGGGACAGM 300 GAGMTCCCC .AAACCTACTA nATCCTGTG GCTGTAGTGA AG.UAGGTTT CAACITTCAG 360 CTG,^CCAGC TAC^GGTCG \AAGTCCIGC CAQCAGGCC nGGCAGGTC TGCCGGGTGG 420 .^TATCCCTA TAGGCITACT TCGCCCGTTC nGGACTGGG CAGGCCCACC TGAGCCCCTC 480 C\QAAACa〇 ΊΟΧΖλλ\ΊΊ dTCTCTCAG AGCTGTGTGC CCTCCGC\GA TO.UATGCG 540 TA丁CCCAACC TGTGTCAGCT GTGCATAGGG AAAGGGAAAG ATAAATGTGC nGTTCCTCC 600 CAGG^ACCGT AinTGGCTA nCCCGTGCC naACTGTC TGCACUACG GAnGGAGAT 660 GTGGCTITTG TCAAGGAGAG TACACTGTTT GAGAACCTGC QCAG.AAGGC TGACCGGGAC 720 <UATACGACC TACTCTGCCC AGACUTACT CGAAAGCCAG TGG.A.AGCATT CAGGGAGTGC 730 CACCTTGCCC GGGTCCCTTC TCATGCTCTlT GTGGCCCGAA GTGTC.UTGG CUGGAGMC 840 TCCATCTGGG AGCTTCrCTA CCAGTCACAG kAAAAGmG βλλ\λ\Χλλ TCCACAGGAG 900 nCCAGCTCT nGGCTCTCC TGGTCAGCAG .^GGACCTCC TGTITAGAGA TGCTACCATC 960 GCGTITITGA AGATCCCCTC AAAGATAGAT TCTAAGCTGT ACCTGGGCCT CCCGTACCTT 1020 ACTGCCATCC ACGGCCTGAG GGAAACCGCA GCGGAGGTGG AGGCGCGGCA GGCGAAGGTC 1080 GTGTGGTGCG CCGTCGGTCC AGACGAGCTG CGCMGTGCC GGCAGTGGAG CAGCCAGAGC 1140 AGCCAG^ACC TGMCTGCAG CCTGGCCTCC ACCACCGACG ACTGC\TCGT CCAGGTGCTG 1200 AAAGGAGAAG CTGATGCTAT GACCTTCGA丁 GGAGGATm TCTACACTGC GGGCAAGTGT 1260 GGnTGGTGC CTGTCCTGGC AGAGAACCAA AAATCTCGCC AAAGCAGTAG CTaGACTGT 1320 GTGCATAGAC CMC\CMGG GTATTITGCC GTGGCGGITG TCACGAA^GC ^AATGGTGGT 1380 ATCACCTGGA ACTCTGTGAG AGGCACGMG TCCTGCCAa CTGCTGTGGA CACGAQGCA i440 GOTGGMCA TCCCCATGGG CCTGOTGTC AACCAGACAG GCTCCTGOA ATTTGACGAA 1500 TTCTTTAGTC AAACCTGTCC TCCTGGGTCT CAGCCGGGAT CCA.ATCTCTG TGCACTGTGT 1560 CTTGCC.A.ATG ACCAGGGCGT GGACMGTGT GTCCCC.AACA GmTGAGAG ATACTATGGT 1620 TACACCGCGG OTTCAGGTG CCTGGCTGAG AATGCTGGGG ATGTGGCGTT TGTGMAGAT 1680 GTCACTGTCT TGGACAACAC GAATCGACAG ^ACACAG.^AC ACTGGGCCAG GGMnGAGG 1740 TCAGATGACT nGAGCTCCT GTCCCTT.A.AT GGCACCACGA ACCCTCTGAC TGACGCTCAG 1800 .A.ACTGTCACC TGGCTGTGGC CCCCAGTCAT GCTGTCGTCT CTCGC.^AGGA .UACGCAGCA I860 CACGTGG.A.AC ACGTGCrACT CACTGAGCAG GCTCAGTTTG GAAGATACGG ^UAGACTCC 1920 CCGGACAAGT πταη^π CCGGTCTGAG ACCAAAAACC UCTGTTCAA CGACAACACG 1980 GAGTGTCTGG CCCWCICQX AGCC.WACA ACAT\CG.^A MTATTTGGG ATCAGAGTAT 2040 OTCACACCCA TCOTAACCT GAAACAGTGC TCAOTCTCCC CCaTCTGGA AGCCTGTGCC 2100 HCATCATGA GGTAA 2115558565 / 々 · -.1? · ^ Lean version 6. Scope of patent application Patent scope: 1. A type of Saccharomyces cerevisiae YES15 (CCRC 9403 10), which includes a plastid YLF, which contains a code The sequence of the polydeoxyribonucleic acid (c DNA) of porcine lactoferrin is as follows: ATGAAGCTCT TCATCCCCGC CCTCCTGm CTCTGGACAC nGGACTGTG TCTCaTCrCC 60 CCTk \ Q ^ \ G CCOTTCGATG GTGTGTCATA TCCACACCAG AGTAHC.UA ATCCCCTCAG 120 TGGC.ATCACT ACT ACT ACT UAC <..} AGGGC nCTCCCACT 180 GACTGTATCC GGGCCATCGC GGCAA \ AAGG GCAGATGCTG TGACCCITGA TGGTGGTITG 240 GTGTTTC ^ G CAGCCCAGTA CUACTGCGG CCGGTAGCAG CGGAGATCTA CGGGACAGM 300 GAGMTCCCC .AAACCTACTA nATCCTGTG GCTGTAGTGA AG.UAGGTTT CAACITTCAG 360 CTG, ^ CCAGC TAC ^ GGTCG \ AAGTCCIGC CAQCAGGCC nGGCAGGTC TGCCGGGTGG 420. ^ TATCCCTA TAGGCITACT TCGCCCGTTC nGGACTGGG CAGGCCCACC TGAGCCCCTC 480 C \ QAAACa〇Ί〇Χλλλ \ ΊΊ dTCTCTCAG AGCTGTGTGC CCTCCGC \ GA TO.UATGCG 540 TA 丁 CCCAACC TGTGTCAGCT GTGCATAGGG AAACCGGTGTG nCGACT naACTGTC TGCACUACG GAnGGAGAT 660 GTGGCTITTG TCAAGGAGAG TACACTGTTT GAGAACCTGC QCAG.AAGGC TGACCGGGAC 720 < UATACGACC TACTCTGCCC AGACUTACT CGAAAGCCAG TGG.A.AGCATT CAGGGAGTGC 730 CACCTTGCCC GGGTCCCTTC TCATGCTCTlT GTGGCCCGAA GTGTC.UTGG CUGGAGMC 840 TCCATCTGGG AGCTTCrCTA CCAGTCACAG kAAAAGmG βλλ \ λ \ Χλλ TCCACAGGAG 900 nCCAGCTCT nGGCTCTCC TGGTCAGCAG. ^ GGACCTCC TGTITAGAGA TGCTACCATC 960 GCGTITITGA AGATCCCCTC AAAGATAGAT TCTAAGCTGT ACCTGGGCCT CCCGTACCTT 1020 ACTGCCATCC ACGGCCTGAG GGAAACCGCA GCGGAGGTGG AGGCGCGGCA GGCGAAGGTC 1080 GTGTGGTGCG CCGTCGGTCC AGACGAGCTG CGCMGTGCC GGCAGTGGAG CAGCCAGAGC 1140 AGCCAG ^ ACC TGMCTGCAG CCTGGCCTCC ACCACCGACG ACTGC \ TCGT CCAGGTGCTG 1200 AAAGGAGAAG CTGATGCTAT GACCTTCGA butoxy GGAGGATm TCTACACTGC GGGCAAGTGT 1260 GGnTGGTGC CTGTCCTGGC AGAGAACCAA AAATCTCGCC AAAGCAGTAG CTaGACTGT 1320 GTGCATAGAC CMC \ CMGG GTATTITGCC GTGGCGGITG TCACGAA ^ GC ^ AATGGTGGT 1380 ATCACCTGGA ACTCTGTGAG AGGCACGMG TCCTGCCAa CTGCTGTGGA CACGAQGCA i440 GOTGGMCA TCCCCATGGG CCTGOTGTC AACCGOAACAGAG TTGACGAA 1500 TTCTTTAGTC AAACCTGTCC TCCTGGGTCT CAGCCGGGAT CCA.ATCTCTG TGCACTGTGT 1560 CTTGCC.A.ATG ACCAGGGCGT GGACMGTGT GTCCCC.AACA GmTGAGAG ATACTATGGT 1620 TACACCGCGG OTTCAGGTG CCTGGCTGAG AATGCTGGGG ATGTGGCGTT TGTGMAGAT 1680 GTCACTGTCT TGGACAACAC GAATCGACAG ^ ACACAG. ^ AC ACTGGGCCAG GGMnGAGG 1740 TCAGATGACT nGAGCTCCT GTCCCTT.A.AT GGCACCACGA ACCCTCTGAC TGACGCTCAG 1800 .A.ACTGTCACC TGGCTGTGGC CCCCAGTCAT GCTGTCGTCT CTCGC. ^ AGGA .UACGCAGCA I860 CACGTGG.A.AC ACGTGCrACT CACTGAGCAG GCTCAGTTTGGAAGCACCCACCACCGGCCAC ATCAGAGTAT 2040 OTCACACCCA TCOTAACCT GAAACAGTGC TCAOTCTCCC CCaTCTGGA AGCCTGTGCC 2100 HCATCATGA GGTAA 2115 第29頁Page 29
TW89118646A 2000-09-08 2000-09-08 The process for preparing the yeast containing recombinant lactoferrin TW558565B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW89118646A TW558565B (en) 2000-09-08 2000-09-08 The process for preparing the yeast containing recombinant lactoferrin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW89118646A TW558565B (en) 2000-09-08 2000-09-08 The process for preparing the yeast containing recombinant lactoferrin

Publications (1)

Publication Number Publication Date
TW558565B true TW558565B (en) 2003-10-21

Family

ID=32311022

Family Applications (1)

Application Number Title Priority Date Filing Date
TW89118646A TW558565B (en) 2000-09-08 2000-09-08 The process for preparing the yeast containing recombinant lactoferrin

Country Status (1)

Country Link
TW (1) TW558565B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112940956A (en) * 2021-04-18 2021-06-11 江南大学 Pichia pastoris for enhancing lactoferrin expression by adopting double promoters and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112940956A (en) * 2021-04-18 2021-06-11 江南大学 Pichia pastoris for enhancing lactoferrin expression by adopting double promoters and application thereof

Similar Documents

Publication Publication Date Title
AU2002220561C1 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
CN106661541A (en) Recombinant host cell engineered to overexpress helper proteins
CA2818467A1 (en) Recombinant microorganisms
CN111718951A (en) Recombinant novel coronavirus COVID-19S protein, preparation method and application thereof
CN108085308B (en) Recombinant engineering bacterium capable of improving yield of heat-resistant lipase and construction method and application thereof
JPS62275695A (en) Production of mature type human serum albumin
AU2002220561A1 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
CN112210519A (en) Genetically engineered bacterium for secreting acetaldehyde dehydrogenase by using edible fungi
CN111763256A (en) Cloning of chicken CR2 gene, expression and purification of protein and preparation of polyclonal antibody thereof
CN101638660A (en) Construction of lactobacillus acidophilus S-layer protein surface display system
CN109897857B (en) Optimized human interleukin-2 gene and its expression method and application
CN109997970B (en) Acidic xylanase mutant with improved enzyme activity and heat resistance, and coding gene and application thereof
TW558565B (en) The process for preparing the yeast containing recombinant lactoferrin
CN115725002B (en) Coli specific antigen fusion protein and recombinant lactococcus lactis thereof
CN114540385B (en) Method for producing lysostaphin by using escherichia coli
JP3681982B2 (en) Method for mass production of lactoferrin polypeptides from yeast and microbial strains useful therefor
CN104418945A (en) Preparation method of peptide and application of peptide in preparation of medicine and feed additive
CN102181437A (en) gAd gene of porcine globular adiponectin and protein encoded by gAd gene and application
JP2023532703A (en) Amuc-1100 Polypeptide Variants to Confer Immune Signaling and/or Affect Intestinal Barrier Function and/or Modulate Metabolic State
CN112094853A (en) White spot syndrome virus VP28 gene, recombinant protein, polyclonal antibody, preparation method and application
TWI414244B (en) Recombinant polypeptide having pancreatic lipase activity and nucleic acid coding sequence thereof, and production and use of the same
CN114746548A (en) Nucleic acids, vectors, host cells and methods for producing fructosyltransferase from aspergillus japonicus
CN100500844C (en) High secretion expression of recombination thymosin-alpha 1 in Escherichia coli and separation and purification therefor
CN115819625B (en) Escherichia coli tetravalent antigen fusion polypeptide
CN115992117B (en) Recombinant human lysozyme and preparation method and application thereof

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent